Physician profile
Mark K Perezous
NPI 1992706253
$2,309.43
in general payments reported to CMS, 2019-2025
7 companies · $201 in 2025
The $201 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $268 · 2021: $145 · 2022: $141 · 2023: $506 · 2024: $824 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $987 · Travel and Lodging: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $986.61 |
| Travel and Lodging | $544.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electronic Waveform Lab, INC. | $1,399.47 | 2019-2025 | |
| Arthrex, INC. | $544.09 | 2024 | |
| Miach Orthopaedics, INC. | $165.88 | 2023 | |
| Smith+Nephew, INC. | $123.38 | 2019-2021 | |
| Bioventus LLC | $37.68 | 2023 | Durolane |
| Depuy Synthes Sales INC. | $19.48 | 2021 | |
| Kerecis Limited | $19.45 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Perezous listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.